Catalyst Wire Dossier Catalyst Wire Dossier

SALFOAM 3% Foam

polidocanol foam 3%
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SALFOAM 3% Foam, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of the SALFOAM 3% Method Compared to the Conventional Polidocanol Foam Method (Tessari Method) for Treating Lower Limb Varicose Veins [NA]

See pricing